◆
GHK-Cu rebuilds skin at the cellular level through collagen synthesis and deep dermal repair.

Dose ranges reflect commonly studied amounts in published research models. This is not medical advice. For research use only. Not for human consumption.
Protocol Comparison
Regeneration · Skin · Recovery
Research dose range
Standard research range
0.75 - 1.5 mg
Most referenced range for the triple-compound regenerative protocol across skin and recovery research.
Research focus
Full regeneration
Observed window
8-12 weeks
Administration
Daily
Primary pathway
GHK-Cu / BPC-157 / TB-500
GLOW Blend is Nova Labs' most comprehensive formulation. Research reflects combined compound interactions.
PROTOCOL BENEFITS
◆
GHK-Cu rebuilds skin at the cellular level through collagen synthesis and deep dermal repair.
◆
TB-500 and BPC-157 work in tandem on systemic and localized tissue recovery.
◆
Three peptides. One protocol. Complete regeneration, inside and out.
SCIENCE
GLOW Blend combines GHK-Cu, TB-500, and BPC-157 into one precision regenerative protocol.
Together, they create a cascade that addresses skin aging, tissue recovery, inflammation, and structural repair simultaneously.
WHAT TO EXPECT
Skin quality improvements are typically visible within 4-6 weeks. Combined tissue healing and recovery benefits develop over 8-12 weeks.
PROTOCOL NOTE
50mg GHK-Cu + 10mg TB-500 + 10mg BPC-157 per vial. For research use only.
FAQ
GLOW Blend combines skin-focused copper peptide signaling with tissue recovery compounds for a broader regeneration profile.
GHK-Cu centers on skin and repair pathways, while GLOW Blend adds TB-500 and BPC-157 for systemic and localized tissue recovery.
RELATED PRODUCTS